Vyhľadávanie
Čeština
  • English
  • 正體中文
  • 简体中文
  • Deutsch
  • Español
  • Français
  • Magyar
  • 日本語
  • 한국어
  • Монгол хэл
  • Âu Lạc
  • български
  • Bahasa Melayu
  • فارسی
  • Português
  • Română
  • Bahasa Indonesia
  • ไทย
  • العربية
  • Čeština
  • ਪੰਜਾਬੀ
  • Русский
  • తెలుగు లిపి
  • हिन्दी
  • Polski
  • Italiano
  • Wikang Tagalog
  • Українська Мова
  • Ostatní
  • English
  • 正體中文
  • 简体中文
  • Deutsch
  • Español
  • Français
  • Magyar
  • 日本語
  • 한국어
  • Монгол хэл
  • Âu Lạc
  • български
  • Bahasa Melayu
  • فارسی
  • Português
  • Română
  • Bahasa Indonesia
  • ไทย
  • العربية
  • Čeština
  • ਪੰਜਾਬੀ
  • Русский
  • తెలుగు లిపి
  • हिन्दी
  • Polski
  • Italiano
  • Wikang Tagalog
  • Українська Мова
  • Ostatní
Název
Transcript
Nasleduje
 

Professor Yaakov Nahmias: Bioengineering for a Better World

Podrobnosti
Stiahnuť Docx
Čítajte viac
February 2014 saw Dr. Nahmias win a Rappaport Prize for Excellence in Biomedical Research. Collaborating with investigators at Massachusetts General Hospital in the US, he identified a grapefruit molecule called naringenin that can block virus replications. Later that year, he became an associate professor at his university and took charge of the MicroLiver Technologies Laboratory, studying liver development, regeneration, and metabolism.

By early 2017, Professor Nahmias had pieced together various aspects of his academic work and was ready to focus on his first entrepreneurial goal. He founded Tissue Dynamics Ltd., a biotechnology company that develops and provides advanced toxicology screening services for the pharmaceutical and cosmetic industries. Professor Nahmias and his company produced a model of the human kidney. But they also embedded electro-optical microsensors into the tissues for constant monitoring throughout experiments. In this way, they knew in real time how a drug was working and when it was not.

Under the guidance of Professor Nahmias, Tissue Dynamics is leading the way to a future where human-on-a-chip technology accelerates the pace and reduces the cost of developing new drugs while keeping our furry friends out of the laboratory.

He founded Future Meat Technologies in April 2018 and once again assumed the responsibilities of a chief scientific officer. Upon completion, the company began producing 500 kilograms of cultured meat daily. As it turned out, the genetic complexity of Future Meat’s product gave it the texture, authentic smell, and flavor that the public wanted.

By November 2021, the company’s founder and chief scientific officer had also become its president. The following year, he changed the firm’s name to Believer Meats and decided to open a commercial-scale production center in North Carolina, USA. Construction began in December 2022 on an 18,000-square-meter facility that will cultivate beef, pork, lamb and chicken meat without killing any animal-people.
Sledujte viac
Najnovšie videá
2024-11-09
1310 Zobrazenia
2024-11-09
620 Zobrazenia
36:12

Pozoruhodné správy

142 Zobrazenia
2024-11-09
142 Zobrazenia
2024-11-09
267 Zobrazenia
2024-11-09
634 Zobrazenia
2024-11-08
903 Zobrazenia
2024-11-08
920 Zobrazenia
32:16

Pozoruhodné správy

253 Zobrazenia
2024-11-08
253 Zobrazenia
Zdieľajte
Zdieľať s
Vložiť
Spustit v čase
Stiahnuť
Mobil
Mobil
iPhone
Android
Sledujte v mobilnom prehliadači
GO
GO
Prompt
OK
Aplikácie
Naskenujte QR kód alebo si vyberte správny telefónny systém na stiahnutie
iPhone
Android